Exhibit 99.2
|
|
Dividends
No dividend has been declared or paid by the Company since its incorporation.
Reconciliation between US GAAP and International Financial Reporting Standards
These interim unaudited condensed consolidated financial statements are prepared in accordance with US GAAP, which differ in certain respects from International Financial Reporting Standards (“IFRS”). The effects of material differences prepared under US GAAP and IFRS are as follows:
(i) Reconciliation of condensed consolidated statements of operations
| | Six Months Ended June 30, 2026 | ||||||
| | | | IFRS adjustments | | | ||
| | | | | | Tax effects of | | |
| | Amounts as | | Lease | | intercompany | | |
| | reported under | | amortization | | unrealized profit | | Amounts |
| | US GAAP | | (note (a)) | | (note (b)) | | under IFRS |
| | (in US$’000) | ||||||
Cost of goods — third parties | | (127,275) | | 1 | | — | | (127,274) |
Research and development expenses | | (78,783) | | 31 | | — | | (78,752) |
Selling expenses |
| (14,682) | | 11 | | — |
| (14,671) |
Administrative expenses |
| (31,795) | | 51 | | — |
| (31,744) |
Total operating expenses |
| (277,418) | | 94 | | — |
| (277,324) |
Other income, net |
| 12,784 | | (110) | | — |
| 12,674 |
Income before income taxes and equity in earnings of equity investees |
| 13,653 | | (16) | | — |
| 13,637 |
Equity in earnings of equity investees, net of tax |
| 3,798 | | (1) | | (11) |
| 3,786 |
Net income |
| 16,242 | | (17) | | (11) |
| 16,214 |
Less: Net income attributable to non-controlling interests |
| (314) | | (2) | | — |
| (316) |
Net income attributable to the Company |
| 15,928 | | (19) | | (11) |
| 15,898 |
| | Six Months Ended June 30, 2025 | ||||||||
| | | | IFRS adjustments | | | ||||
| | | | | | Tax effects of | | | | |
| | Amounts as | | Lease | | intercompany | | Capitalization | | |
| | reported under | | amortization | | unrealized profit | | of rights | | Amounts |
| | US GAAP | | (note (a)) | | (note (b)) | | (note (c)) | | under IFRS |
| | (in US$’000) | ||||||||
Cost of goods — third parties | | (147,601) | | 7 | | — | | — | | (147,594) |
Research and development expenses |
| (71,990) | | 40 | | — | | (16,109) | | (88,059) |
Selling expenses |
| (13,873) | | 11 | | — | | — | | (13,862) |
Administrative expenses |
| (27,751) | | 26 | | — | | — | | (27,725) |
Total operating expenses |
| (281,191) | | 84 | | — | | (16,109) | | (297,216) |
Gain on divestment of an equity investee | | 477,456 | | 18 | | (151) | | — | | 477,323 |
Other income, net |
| 21,650 | | (104) | | — | | — | | 21,546 |
Income before income taxes and equity in earnings of equity investees |
| 495,592 | | (2) | | (151) | | (16,109) | | 479,330 |
Equity in earnings of an equity investee, net of tax |
| 23,125 | | 6 | | (91) | | — | | 23,040 |
Net income |
| 455,555 | | 4 | | (242) | | (16,109) | | 439,208 |
Less: Net income attributable to non-controlling interests |
| (601) | | 3 | | — | | 25 | | (573) |
Net income attributable to the Company |
| 454,954 | | 7 | | (242) | | (16,084) | | 438,635 |
1
|
|
(ii) Reconciliation of condensed consolidated balance sheets
| | June 30, 2026 | ||||||||
| | | | IFRS adjustments | | | ||||
| | | | | | Tax effects of | | | | |
| | Amounts as | | Lease | | intercompany | | Issuance | | |
| | reported under | | amortization | | unrealized profit | | costs | | Amounts |
| | US GAAP | | (note (a)) | | (note (b)) | | (note (d)) | | under IFRS |
| | (in US$’000) | ||||||||
Investment in equity investees | | 11,020 | | (2) | | 13 | | — | | 11,031 |
Other non-current assets | | 34,189 | | (104) | | — | | — | | 34,085 |
Total assets |
| 1,736,427 | | (106) | | 13 |
| — |
| 1,736,334 |
| | | | | | | | | | |
Total liabilities |
| 461,459 | | — | | — |
| — |
| 461,459 |
| | | | | | | | | | |
Additional paid-in capital |
| 1,539,439 | | — | | — |
| (697) |
| 1,538,742 |
Accumulated losses |
| (362,715) | | (105) | | 13 |
| 697 |
| (362,110) |
Accumulated other comprehensive loss |
| (3,182) | | 9 | | — |
| — |
| (3,173) |
Total Company’s shareholders’ equity |
| 1,260,776 | | (96) | | 13 |
| — |
| 1,260,693 |
Non-controlling interests |
| 14,192 | | (10) | | — |
| — |
| 14,182 |
Total shareholders’ equity |
| 1,274,968 | | (106) | | 13 |
| — |
| 1,274,875 |
| | December 31, 2025 | ||||||||||
| | | | IFRS adjustments | | | ||||||
| | | | | | Tax effects of | | | | | | |
| | Amounts as | | Lease | | intercompany | | Issuance | | | | |
| | reported under | | amortization | | unrealized profit | | costs | | LTIP classification | | Amounts |
| | US GAAP | | (note (a)) | | (note (b)) | | (note (d)) | | (note (e)) | | under IFRS |
| | (in US$’000) | ||||||||||
Investment in equity investees | | 10,865 | | (1) | | 24 | | — | | — | | 10,888 |
Other non-current assets | | 38,886 | | (86) | | — | | — | | — | | 38,800 |
Total assets |
| 1,753,097 | | (87) | | 24 | | — | | — | | 1,753,034 |
| | | | | | | | | | | | |
Other payables and accruals |
| 208,892 | | — | | — | | — | | (883) | | 208,009 |
Total current liabilities |
| 315,775 | | — | | — | | — | | (883) | | 314,892 |
Total liabilities |
| 501,835 | | — | | — | | — | | (883) | | 500,952 |
| | | | | | | | | | | | |
Additional paid-in capital |
| 1,533,868 | | — | | — | | (697) | | 883 | | 1,534,054 |
Accumulated losses |
| (378,643) | | (86) | | 24 | | 697 | | — | | (378,008) |
Accumulated other comprehensive loss |
| (4,532) | | 11 | | — | | — | | — | | (4,521) |
Total Company’s shareholders’ equity |
| 1,237,926 | | (75) | | 24 | | — | | 883 | | 1,238,758 |
Non-controlling interests |
| 13,336 | | (12) | | — | | — | | — | | 13,324 |
Total shareholders’ equity |
| 1,251,262 | | (87) | | 24 | | — | | 883 | | 1,252,082 |
2
|
|
Notes:
(a) | Lease amortization |
Under US GAAP, for operating leases, the amortization of right-of-use assets and the interest expense element of lease liabilities are recorded together as lease expenses, which results in a straight-line recognition effect in the condensed consolidated statements of operations.
Under IFRS, all leases are accounted for like finance leases where right-of-use assets are generally depreciated on a straight-line basis while lease liabilities are measured under the effective interest method, which results in higher expenses at the beginning of the lease term and lower expenses near the end of the lease term.
(b) | Tax effects of intercompany unrealized profit |
Under US GAAP, deferred taxes for unrealized profit resulting from intercompany sales of inventory is not recognized.
Under IFRS, deferred taxes for unrealized profit resulting from an intercompany sale of inventory is recognized at the buyer’s tax rate.
(c) | Capitalization of development and commercial rights |
Under US GAAP, the acquired development and commercial rights do not meet the capitalization criteria as further development is needed as of the acquisition date and there is no alternative future use. Such rights are considered as IPR&D and were expensed to research and development expenses.
Under IFRS, the acquired development and commercial rights were capitalized to intangible assets. The recognition criterion is always assumed to be met as the price already reflects the probability that future economic benefits will flow to the Group. As at June 30, 2026, the intangible asset has been fully impaired.
(d) | Issuance costs |
Under US GAAP and IFRS, there are differences in the criteria for capitalization of issuance costs incurred in the offering of equity securities.
(e) | LTIP classification |
Under US GAAP, LTIP awards with performance conditions are classified as liability-settled awards prior to the determination date as they settle in a variable number of shares based on a determinable monetary amount, which is determined upon the actual achievement of performance targets. After the determination date, the LTIP awards are reclassified as equity-settled awards.
Under IFRS, LTIP awards are classified as equity-settled awards, both prior to and after the determination date, as they are ultimately settled in ordinary shares or the equivalent ADS of the Company instead of cash.
3